The future of pancreatic cancer care

<p>Pancreatic cancer survival rates have doubled in the last few years from 5 to 10 percent. This is thanks largely to clinical trials that have led to better treatments and a better understanding of how to tailor them to the individual. Despite the advancements, pancreatic cancer remains difficult to treat and long-term survival remains low. But, experts are hopeful that cutting-edge technology such as organoids — a collection of a patient’s cells that are maintained in a petri dish — will lead to continued improvements in outcomes.</p> <p>Featured speakers: <a href='https://www.northwell.edu/find-care/find-a-doctor/surgery/dr-matthew-john-weiss-md-11381146'>Matthew Weiss, MD</a>, physician-in-chief and director of surgical oncology for the Northwell Cancer Institute; and <a href='https://health.ucdavis.edu/team/surgery/32184/sepideh-gholami---cancer---surgery---oncology---hepatobiliary-surgery---liver-cancer-surgery-sacramento'>Sepideh Gholami, MD</a>, F.A.C.S., cancer specialist and surgeon at UC-Davis in California.</p>